Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hanwha Ocean (042660) – Execution of Sales / Supply Contract / 2026-08-03

Posted on August 3, 2026August 8, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Ocean (042660) – Execution of Sales / Supply Contract / 2026-08-03

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hanwha Ocean has entered into an EPC contract worth approximately KRW 527.9B with its affiliate, Yeosu Eco Energy Co., Ltd., for the Yeosu Eco Energy LNG Cogeneration Project (490MW), representing 4.1% of its recent annual revenue.

📊 [Key Disclosure Details & Financial Figures]

  • Contract Title: Yeosu Eco Energy LNG Cogeneration Project (490MW) EPC Contract
  • Contract Type: Construction Order
  • Contract Amount: KRW 527,900,000,000 (Approx. KRW 527.9B)
  • Recent Annual Revenue: KRW 12,783,500,000,000 (Based on end-2025 consolidated financial statements, rounded to nearest 100M KRW)
  • Ratio to Revenue: 4.1%
  • Counterparty: Yeosu Eco Energy Co., Ltd. (Affiliate)
  • Location: Sandanjungang-ro, Yeosu-si, Jeollanam-do
  • Contract Period: August 3, 2026 ~ August 31, 2029
  • Key Conditions: Down payment/advance payment included; collection based on construction progress
  • Contract (Order) Date: August 3, 2026
  • Other Remarks: Contract period and final settlement amount are subject to change during construction

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Monitoring Construction Progress and Potential Adjustments to Contract Period and Final Amount

This disclosure reports the receipt of an EPC construction order valued at approximately KRW 527.9B from affiliate Yeosu Eco Energy Co., Ltd. Because the agreement states that the contract period and final settlement amount are subject to change during execution, tracking actual construction progress and any subsequent adjustments to contract terms is essential. Investors can verify further developments through subsequent disclosures as well as Quarterly, Half-Yearly, and Annual Reports.

📢 Disclaimer and Source Notice

Source: This content was structured and newly generated based on official submission data from the Financial Supervisory Service DART system.

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial liabilities rest entirely with the individual investor.

Contact: For regulatory compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Shipbuilding

Post navigation

Previous Post: [Disclosure] Hana Micron (067310) – Setting of Closure Period of Shareholders’ Register or Record Date / 2024-12-16
Next Post: [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03

Related Posts

[Disclosure] Samsung Electro-Mechanics (009150) – Future Business/Management Plan (Fair Disclosure) / 2026-07-03 Semiconductors
[Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-04-23 Semiconductors
[Disclosure] Samsung Electronics (005930) – (Correction) Consolidated Earnings Estimate (Disclosure) / 2024-10-31 Semiconductors
[Disclosure] Hanwha Ocean (042660) – Signing of Single Sales/Supply Contract / 2025-03-17 Disclosures
[Disclosure] Wonik IPS (240810) – Setting of Record Date or Period for Suspension of Entry of Change in Shareholders’ Register / 2026-07-24 Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Corporate Value-Up Plan / 2025-12-26 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme